| Target | Probe | Control | Targeted domain | Mode of action | Recommended concentration | Target origin |
|---|---|---|---|---|---|---|
| CFTR | A-1596586 | A-1596584 | — | Corrector | ≤ 1 µM | human |
| TRPA1 | A-079 | A-226 | — | Antagonist | 1 µM | human |
| P2RX4 | BAY-1797 | BAY-207 | — | Inhibitor | 0.1 - 1 µM | human |
| TRPA1 | BAY-390 | BAY-9897 | — | Inhibitor | 100 nM | human |
| Epithelial sodium channel | BI-8668 | BI-0337 | — | Inhibitor | 1 µM | human |
| SLC9A1 | BI-9627 | BI-0054 | — | Antagonist | ≤ 5 µM | human |
| GRIN2A | JNJ-78911118 | JNJ-77914993 | GRIN1/GRIN2A interface | Negative Allosteric Modulator | ≤ 10 µM | human |
| TRPM8 | PF-05105679 | PF-05257137 | — | Antagonist | 1 µM | human |
| GABRA5 | RO4938581 | RO4991571 | — | Negative allosteric modulator | ≤ 1 µM | human |
| HCN1 | RO-275 | RO7239047 | — | Suppressor | 1 µM | human |
| GRIN2A | TP-050 | TP-050n | GRIN1/GRIN2A ligand binding domain (Tyr 144) | Positive allosteric modulator | ≤ 30 µM | human |